Reference
Betlachin A, et al. Severe Hypophosphatemia and Elevated FGF23 Level Following Zoledronic Acid Infusion. Journal of the Endocrine Society 5 (Suppl.): A220-A221, May 2021. Available from: URL: https://dx.doi.org/10.1210/jendso/bvab048.448 [abstract]
Rights and permissions
About this article
Cite this article
Adalimumab/zoledronic-acid. Reactions Weekly 1984, 21 (2023). https://doi.org/10.1007/s40278-023-50252-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-50252-9